Howard Levy
Corporate Officer/Principal bei Society of Critical Care Medicine
Profil
Howard Levy is a member of the Society of Critical Care Medicine.
He previously worked as a Medical Director-Acute Care at Eli Lilly & Co., Senior Director-Global Medical Program at CSL Behring LLC, Chief Medical Officer at Inspiration Biopharmaceuticals, Inc., Chief Medical Officer at Sangart, Inc., and Associate VP-Clinical Research & Medical at Novo Nordisk, Inc. He also served as the Chief-Critical Care Medicine at The University of New Mexico.
Dr. Levy's education includes a graduate degree from Carnegie Mellon University and a doctorate from the University of the Witwatersrand.
Currently, he is the Chief Medical Officer at Catalyst Biosciences, Inc. and will be the Chief Medical Officer at Ampio Pharmaceuticals, Inc. from 2021 to 2023.
Aktive Positionen von Howard Levy
Unternehmen | Position | Beginn |
---|---|---|
Society of Critical Care Medicine
Society of Critical Care Medicine Miscellaneous Commercial ServicesCommercial Services The Society of Critical Care Medicine is a non-profit medical organization founded in 1970. The non-profit company is based in Des Plaines, IL. The company promotes the practice of critical care. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Howard Levy
Unternehmen | Position | Ende |
---|---|---|
AMPIO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01.07.2023 |
CATALYST BIOSCIENCES | Chief Tech/Sci/R&D Officer | 15.08.2021 |
Sangart, Inc.
Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01.01.2011 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Corporate Officer/Principal | 01.01.2008 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | - |
Ausbildung von Howard Levy
Carnegie Mellon University | Graduate Degree |
University of the Witwatersrand | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
AMPIO PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | Health Technology |
Sangart, Inc.
Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Society of Critical Care Medicine
Society of Critical Care Medicine Miscellaneous Commercial ServicesCommercial Services The Society of Critical Care Medicine is a non-profit medical organization founded in 1970. The non-profit company is based in Des Plaines, IL. The company promotes the practice of critical care. | Commercial Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
Catalyst Biosciences, Inc.
Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |